LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 26

Search options

  1. Article ; Online: Better governance starts with better words: why responsible human tissue research demands a change of language.

    Lensink, Michael A / Jongsma, Karin R / Boers, Sarah N / Bredenoord, Annelien L

    BMC medical ethics

    2022  Volume 23, Issue 1, Page(s) 90

    Abstract: The rise of precision medicine has led to an unprecedented focus on human biological material in biomedical research. In addition, rapid advances in stem cell technology, regenerative medicine and synthetic biology are leading to more complex human ... ...

    Abstract The rise of precision medicine has led to an unprecedented focus on human biological material in biomedical research. In addition, rapid advances in stem cell technology, regenerative medicine and synthetic biology are leading to more complex human tissue structures and new applications with tremendous potential for medicine. While promising, these developments also raise several ethical and practical challenges which have been the subject of extensive academic debate. These debates have led to increasing calls for longitudinal governance arrangements between tissue providers and biobanks that go beyond the initial moment of obtaining consent, such as closer involvement of tissue providers in what happens to their tissue, and more active participatory approaches to the governance of biobanks. However, in spite of these calls, such measures are being adopted slowly in practice, and there remains a strong tendency to focus on the consent procedure as the tool for addressing the ethical challenges of contemporary biobanking. In this paper, we argue that one of the barriers to this transition is the dominant language pervading the field of human tissue research, in which the provision of tissue is phrased as a 'donation' or 'gift', and tissue providers are referred to as 'donors'. Because of the performative qualities of language, the effect of using 'donation' and 'donor' shapes a professional culture in which biobank participants are perceived as passive providers of tissue free from further considerations or entitlements. This hampers the kind of participatory approaches to governance that are deemed necessary to adequately address the ethical challenges currently faced in human tissue research. Rather than reinforcing this idea through language, we need to pave the way for the kind of participatory approaches to governance that are being extensively argued for by starting with the appropriate terminology.
    MeSH term(s) Biological Specimen Banks ; Biomedical Research ; Humans ; Informed Consent ; Language ; Precision Medicine
    Language English
    Publishing date 2022-09-01
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2041552-7
    ISSN 1472-6939 ; 1472-6939
    ISSN (online) 1472-6939
    ISSN 1472-6939
    DOI 10.1186/s12910-022-00823-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Consent for governance in the ethical use of organoids.

    Boers, Sarah N / Bredenoord, Annelien L

    Nature cell biology

    2018  Volume 20, Issue 6, Page(s) 642–645

    MeSH term(s) Bioethical Issues/legislation & jurisprudence ; Biological Specimen Banks/ethics ; Data Anonymization/ethics ; Government Regulation ; Humans ; Informed Consent/ethics ; Informed Consent/legislation & jurisprudence ; Organoids/cytology ; Organoids/physiology ; Patient Participation ; Policy Making ; Privacy ; Stem Cell Research/ethics ; Stem Cell Research/legislation & jurisprudence ; Stem Cells/physiology ; Tissue Donors/ethics ; Tissue Donors/legislation & jurisprudence
    Language English
    Publishing date 2018-05-18
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1474722-4
    ISSN 1476-4679 ; 1465-7392
    ISSN (online) 1476-4679
    ISSN 1465-7392
    DOI 10.1038/s41556-018-0112-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Responsible Research with Human Tissues: The Need for Reciprocity Toward Both Collectives and Individuals.

    Lensink, Michael A / Jongsma, Karin R / Boers, Sarah N / van Delden, Johannes J M / Bredenoord, Annelien L

    The American journal of bioethics : AJOB

    2021  Volume 21, Issue 4, Page(s) 75–78

    MeSH term(s) Cognition ; Cooperative Behavior ; Humans ; Precision Medicine
    Language English
    Publishing date 2021-04-06
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2060433-6
    ISSN 1536-0075 ; 1526-5161
    ISSN (online) 1536-0075
    ISSN 1526-5161
    DOI 10.1080/15265161.2021.1891346
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Mini-gut feelings: perspectives of people with cystic fibrosis on the ethics and governance of organoid biobanking.

    Lensink, Michael A / Boers, Sarah N / M Gulmans, Vincent A / Jongsma, Karin R / Bredenoord, Annelien L

    Personalized medicine

    2021  Volume 18, Issue 3, Page(s) 241–254

    Abstract: Aim: ...

    Abstract Aim:
    MeSH term(s) Adolescent ; Adult ; Biological Specimen Banks/ethics ; Biological Specimen Banks/legislation & jurisprudence ; Biological Specimen Banks/standards ; Biomedical Research ; Commerce ; Cystic Fibrosis/psychology ; Female ; Humans ; Interviews as Topic ; Male ; Middle Aged ; Organoids ; Ownership ; Qualitative Research ; Trust ; Young Adult
    Language English
    Publishing date 2021-04-07
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2299146-3
    ISSN 1744-828X ; 1741-0541
    ISSN (online) 1744-828X
    ISSN 1741-0541
    DOI 10.2217/pme-2020-0161
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Understanding (in) Consent for Governance.

    Lensink, Michael A / Boers, Sarah N / Jongsma, Karin R / Bredenoord, Annelien L

    The American journal of bioethics : AJOB

    2019  Volume 19, Issue 5, Page(s) 43–45

    MeSH term(s) Biological Specimen Banks ; Comprehension ; Genetic Research ; Humans ; Informed Consent
    Language English
    Publishing date 2019-05-15
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2060433-6
    ISSN 1536-0075 ; 1526-5161
    ISSN (online) 1536-0075
    ISSN 1526-5161
    DOI 10.1080/15265161.2019.1587033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Breeding brains? Patients' and laymen's perspectives on cerebral organoids.

    Haselager, Dolly R / Boers, Sarah N / Jongsma, Karin R / Vinkers, Christiaan H / Broekman, Marike L / Bredenoord, Annelien L

    Regenerative medicine

    2021  Volume 15, Issue 12, Page(s) 2351–2360

    Abstract: Aim: ...

    Abstract Aim:
    MeSH term(s) Brain ; Breeding ; Humans ; Organoids ; Tissue Donors
    Language English
    Publishing date 2021-01-20
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2274500-2
    ISSN 1746-076X ; 1746-0751
    ISSN (online) 1746-076X
    ISSN 1746-0751
    DOI 10.2217/rme-2020-0108
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Ethical challenges for pediatric liver organoid transplantation.

    Schneemann, Sarah A / Boers, Sarah N / van Delden, Johannes J M / Nieuwenhuis, Edward E S / Fuchs, Sabine A / Bredenoord, Annelien L

    Science translational medicine

    2020  Volume 12, Issue 552

    Abstract: Liver organoid transplantation may be a less invasive alternative to liver transplant, but is it ethically acceptable to include children with liver disease in a first-in-human clinical trial of this new intervention? ...

    Abstract Liver organoid transplantation may be a less invasive alternative to liver transplant, but is it ethically acceptable to include children with liver disease in a first-in-human clinical trial of this new intervention?
    MeSH term(s) Child ; Humans ; Liver Diseases ; Liver Transplantation ; Organoids
    Language English
    Publishing date 2020-09-22
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2518854-9
    ISSN 1946-6242 ; 1946-6234
    ISSN (online) 1946-6242
    ISSN 1946-6234
    DOI 10.1126/scitranslmed.aau8471
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Organoids for personalized treatment of Cystic Fibrosis: Professional perspectives on the ethics and governance of organoid biobanking.

    Lensink, Michael A / Boers, Sarah N / Jongsma, Karin R / Carter, Sarah E / van der Ent, Cornelis K / Bredenoord, Annelien L

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

    2020  Volume 20, Issue 3, Page(s) 443–451

    Abstract: Background: Organoid technology is emerging rapidly as a valuable tool for precision medicine, particularly in the field of Cystic Fibrosis (CF). However, biobank storage and use of patient-derived organoids raises specific ethical and practical ... ...

    Abstract Background: Organoid technology is emerging rapidly as a valuable tool for precision medicine, particularly in the field of Cystic Fibrosis (CF). However, biobank storage and use of patient-derived organoids raises specific ethical and practical challenges that demand sound governance. We examined the perspectives of professionals affiliated with CF or organoids on the ethical aspects of organoid biobanking for CF precision medicine. By conducting this study parallel to the process of innovation and development of organoid biobanking, its findings are valuable for the design of responsible governance frameworks.
    Methods: To identify relevant themes and attitudes we conducted 21 semi-structured qualitative interviews with professionals in the field of organoid technology, biobanking, or CF research and care.
    Results: We identified three key challenges, as well as the suggestions of professionals on how to address them: (1) The challenges associated with commercial involvement, trust, and ownership, (2) Navigating the blurring boundary between research and clinical care, (3) Appropriate approaches to the informed consent procedure.
    Conclusion: Sound governance of organoid biobanks aimed at precision medicine requires coming to terms with the fact that its stakeholders no longer belong to separate domains. Responsible governance should be aimed at finding a sound, context-sensitive balance between integration of ongoing co-operation and mutual consideration of interests, and maintaining a feasible and sustainable research climate.
    MeSH term(s) Biological Specimen Banks ; Cystic Fibrosis/therapy ; Humans ; Interviews as Topic ; Organoids ; Precision Medicine
    Language English
    Publishing date 2020-12-07
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2084724-5
    ISSN 1873-5010 ; 1569-1993
    ISSN (online) 1873-5010
    ISSN 1569-1993
    DOI 10.1016/j.jcf.2020.11.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Organoids as hybrids: ethical implications for the exchange of human tissues.

    Boers, Sarah N / van Delden, Johannes J M / Bredenoord, Annelien L

    Journal of medical ethics

    2018  Volume 45, Issue 2, Page(s) 131–139

    Abstract: Recent developments in biotechnology allow for the generation of increasingly complex products out of human tissues, for example, human stem cell lines, synthetic embryo-like structures and organoids. These developments are coupled with growing ... ...

    Abstract Recent developments in biotechnology allow for the generation of increasingly complex products out of human tissues, for example, human stem cell lines, synthetic embryo-like structures and organoids. These developments are coupled with growing commercial interests. Although commercialisation can spark the scientific and clinical promises, profit-making out of human tissues is ethically contentious and known to raise public concern. The traditional bioethical frames of gift versus market are inapt to capture the resulting practical and ethical complexities. Therefore, we propose an alternative approach to identify, evaluate and deal with the ethical challenges that are raised by the increasing commercialisation of the exchange of sophisticated human tissue products. We use organoid technology, a cutting-edge stem cell technology that enables the cultivation of 'mini-organs' in a dish, as an example. First, we examine the moral value of organoids and recognise them as hybrids that relate to persons and their bodies as well as to technologies and markets in ambiguous ways. Second, we show that commercialisation of organoids is legitimised by a detachment of the instrumental and commercial value of organoids from their associations with persons and their bodies. This detachment is enacted in steps of disentanglement, among which consent and commodification. Third, we contend that far-reaching disentanglement is ethically challenging: (1) Societal interests could be put under pressure, because the rationale for commercialising organoid technology, that is, to stimulate biomedical innovation for the good of society, may not be fulfilled; (2) The interests of donors are made subordinate to those of third parties and the relational moral value of organoids may be insufficiently recognised. Fourth, we propose a 'consent for governance' model that contributes to responsible innovation and clinical translation in this exciting field.
    MeSH term(s) Ethics, Research ; Humans ; Organoids/transplantation ; Technology Transfer ; Tissue Transplantation/ethics
    Language English
    Publishing date 2018-10-26
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 194927-5
    ISSN 1473-4257 ; 0306-6800
    ISSN (online) 1473-4257
    ISSN 0306-6800
    DOI 10.1136/medethics-2018-104846
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Genome-wide and panel-based cell-free DNA characterization of patients with resectable esophageal adenocarcinoma.

    van den Ende, Tom / van der Pol, Ymke / Creemers, Aafke / Moldovan, Norbert / Boers, Dries / van Berge Henegouwen, Mark I / Hulshof, Maarten Ccm / Cillessen, Saskia Agm / van Grieken, Nicole Ct / Pegtel, D Michiel / Derks, Sarah / Bijlsma, Maarten F / Mouliere, Florent / van Laarhoven, Hanneke Wm

    The Journal of pathology

    2023  Volume 261, Issue 3, Page(s) 286–297

    Abstract: ... III EAC patients with baseline (n = 111), post-neoadjuvant chemoradiotherapy (nCRT) (n = 68), and pre ... surgery (n = 92) plasma samples were used for ctDNA characterization. sWGS (<5× coverage) was performed ...

    Abstract Circulating tumor DNA (ctDNA) holds promise in resectable esophageal adenocarcinoma (EAC) to predict patient outcome but is not yet sensitive enough to be clinically applicable. Our aim was to combine ctDNA mutation data with shallow whole-genome sequencing (sWGS)-derived copy number tumor fraction estimates (ichorCNA) to improve pathological response and survival prediction in EAC. In total, 111 stage II/III EAC patients with baseline (n = 111), post-neoadjuvant chemoradiotherapy (nCRT) (n = 68), and pre-surgery (n = 92) plasma samples were used for ctDNA characterization. sWGS (<5× coverage) was performed on all time-point samples, and copy number aberrations were estimated using ichorCNA. Baseline and pre-surgery samples were sequenced using a custom amplicon panel for mutation detection. Detection of baseline ctDNA was successful in 44.3% of patients by amplicon sequencing and 10.5% by ichorCNA. Combining both, ctDNA could be detected in 50.5% of patients. Baseline ctDNA positivity was related to higher T stage (cT3, 4) (p = 0.017). There was no relationship between pathological response and baseline ctDNA positivity. However, baseline ctDNA metrics (variant allele frequency > 1% or ichorCNA > 3%) were associated with a high risk of disease progression [HR = 2.23 (95% CI 1.22-4.07), p = 0.007]. The non-clearance of a baseline variant or ichorCNA > 3% in pre-surgery samples was related to early progression [HR = 4.58 (95% CI 2.22-9.46), p < 0.001]. Multi-signal analysis improves detection of ctDNA and can be used for prognostication of resectable EAC patients. Future studies should explore the potential of multi-modality sequencing for risk stratification and treatment adaptation based on ctDNA results. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
    MeSH term(s) Humans ; Cell-Free Nucleic Acids/genetics ; Circulating Tumor DNA/genetics ; Adenocarcinoma/genetics ; Adenocarcinoma/therapy ; Adenocarcinoma/diagnosis ; Esophageal Neoplasms/genetics ; Esophageal Neoplasms/therapy ; Biomarkers, Tumor/genetics ; Mutation
    Chemical Substances Cell-Free Nucleic Acids ; Circulating Tumor DNA ; Biomarkers, Tumor
    Language English
    Publishing date 2023-08-24
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3119-7
    ISSN 1096-9896 ; 0022-3417
    ISSN (online) 1096-9896
    ISSN 0022-3417
    DOI 10.1002/path.6175
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top